StockNews.com Downgrades Phibro Animal Health (NASDAQ:PAHC) to Buy

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) was downgraded by investment analysts at StockNews.com from a "strong-buy" rating to a "buy" rating in a research report issued on Sunday.

Several other analysts have also recently weighed in on PAHC. Barclays raised their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an "underweight" rating in a report on Tuesday, November 12th. Morgan Stanley lifted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research report on Tuesday, December 17th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $20.50.

Phibro Animal Health Stock Down 6.7 %

NASDAQ PAHC traded down $1.43 during trading hours on Friday, hitting $20.05. 128,810 shares of the company were exchanged, compared to its average volume of 170,735. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The firm has a market cap of $812.09 million, a price-to-earnings ratio of 46.63, a PEG ratio of 0.58 and a beta of 0.53. The company has a 50 day moving average of $22.75 and a two-hundred day moving average of $21.13. Phibro Animal Health has a 52-week low of $10.03 and a 52-week high of $25.98.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. American Century Companies Inc. raised its position in Phibro Animal Health by 119.6% during the second quarter. American Century Companies Inc. now owns 347,191 shares of the company's stock worth $5,822,000 after acquiring an additional 189,068 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Phibro Animal Health by 5.7% during the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company's stock valued at $13,005,000 after acquiring an additional 42,086 shares during the last quarter. Sofinnova Investments Inc. purchased a new stake in Phibro Animal Health during the 2nd quarter worth about $3,975,000. Hsbc Holdings PLC acquired a new position in Phibro Animal Health in the 2nd quarter valued at about $238,000. Finally, Public Sector Pension Investment Board lifted its holdings in Phibro Animal Health by 6.1% in the 2nd quarter. Public Sector Pension Investment Board now owns 44,796 shares of the company's stock valued at $751,000 after purchasing an additional 2,583 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company's stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.